TJP1 and familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis: This includes CLDN16, as one of the FHHNC-causing variants in CLDN16 disrupts ZO-1 binding, resulting in lysosomal CLDN16 accumulation (47).